Ocera Therapeutics
contact us
  • home
  • about us
  • pipeline
  • therapeutic areas
  • clinical trials
  • partnering and licensing
  • news and events
  • Overview
  • Senior Management Team
  • Board of Directors
  • Scientific Advisors
  • Investors

About Us

Investors

Since its inception in 2005, the company has raised a total of $62 million from premiere life science investors, including Domain Associates, L.L.C., Thomas McNerney & Partners, Sofinnova Ventures and Montagu Newhall Associates. 

 

 

 
Copyright © 2010 Ocera Therapeutics, Inc.